| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/21/2009 | US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563466 Antiinflammatory agents for both viral and non-viral lesions |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | CA2478393C 1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine prevention and treatment |
| 07/21/2009 | CA2409845C Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2386215C Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2348988C Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor |
| 07/21/2009 | CA2288789C Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 07/16/2009 | WO2009088530A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009087988A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | WO2009087949A1 Compound having heterocyclic ring, and use thereof |
| 07/16/2009 | WO2009087938A1 Capsule formulation |
| 07/16/2009 | WO2009045720A3 Electricity-generating particulates and the use thereof |
| 07/16/2009 | WO2008147562A3 Dietary formulations and methods for treatment of inflammation and other disorders |
| 07/16/2009 | US20090182056 Pharmaceutical formulations of amyloid inhibiting compounds |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181919 Method for Freeze-Drying Nucleic Acid/Block Copolymer/Cationic Surfactant Complexes |
| 07/16/2009 | US20090181897 Cxcr4 antagonist and use thereof |
| 07/16/2009 | US20090181107 Solution having biocidal activity |
| 07/16/2009 | US20090181094 Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents |
| 07/16/2009 | US20090181047 Anti-inflammatory hydrolysate of C. versicolor |
| 07/16/2009 | US20090181043 Method for Producing Human Anti-Thymocyte Immunoglobulins |
| 07/16/2009 | US20090181040 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181027 Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181007 Culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related thereto |
| 07/16/2009 | US20090181002 Reduced coenzyme q10-containing composition which is stable against oxidation, and method for stabilization of reduced coenzyme q10 |
| 07/16/2009 | US20090180966 Cancer cell diagnosis by targeting delivery of nanodevices |
| 07/16/2009 | US20090180961 Screening a candidate compound for antiinflammatory activity by administering the candidate in vivo to cells of an animal that express a Reso E receptor; reduced expression of interleukin-12 and reduced migration of dendritic cells into T-cell areas of the spleen indicates a good candidate |
| 07/16/2009 | DE10301300B4 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/16/2009 | CA2711814A1 Capsule formulation |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711611A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | CA2711160A1 Pterin analog for treating bh4 responsive condition |
| 07/15/2009 | EP2078719A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078523A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 07/15/2009 | EP2005954A9 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| 07/15/2009 | EP1675625A4 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | EP1446099B1 Injectable depot composition |
| 07/15/2009 | EP1403279B1 Protein polymer having unfold activity on higher-order structure of protein |
| 07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
| 07/15/2009 | EP1389118B1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | EP1370268B1 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1261335B1 Combination of n-acetyl-l-tryptophan and magnesium sulphate for the treatment of brain, spinal and nerve injury |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513565C Apoptin-associating protein |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100513404C Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560543 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560493 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/14/2009 | US7560474 Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560280 Human cord blood derived unrestricted somatic stem cells (USSC) |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560131 High solubility composition with high isoflavone concentration and process of producing same |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | CA2521133C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2360776C Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders |
| 07/14/2009 | CA2338090C Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies |
| 07/14/2009 | CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084693A1 Antitumor agent |
| 07/09/2009 | WO2009084659A1 Solution preparation containing antibody at high concentration |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |